Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,390.00
+40.00 (0.54%)
At close: Feb 13, 2026
Market Cap28.08B -20.2%
Revenue (ttm)25.86B +7.0%
Net Income1.34B
EPS353.41
Shares Out3.80M
PE Ratio20.91
Forward PEn/a
Dividend75.00 (1.01%)
Ex-Dividend DateDec 29, 2025
Volume57,694
Average Volume115,011
Open7,420.00
Previous Close7,350.00
Day's Range7,320.00 - 7,550.00
52-Week Range6,940.00 - 10,570.00
Beta0.41
RSI55.44
Earnings DateFeb 11, 2026

About KOSDAQ:036480

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1966
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 036480
Full Company Profile

Financial Performance

In 2024, KOSDAQ:036480's revenue was 23.80 billion, a decrease of -6.88% compared to the previous year's 25.56 billion. Losses were -1.77 billion, 160.3% more than in 2023.

Financial Statements